Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
66.69 USD | +0.23% | -0.39% | +7.17% |
04/04 | Boston Scientific, Axonics Receive FTC Second Request on Merger Deal | MT |
04/04 | Boston Scientific, Axonics Merger Prompts FTC to Request Additional Information | DJ |
Sales 2024 * | 448M 37.37B | Sales 2025 * | 534M 44.56B | Capitalization | 3.4B 284B |
---|---|---|---|---|---|
Net income 2024 * | 25M 2.08B | Net income 2025 * | 37M 3.08B | EV / Sales 2024 * | 6.79 x |
Net cash position 2024 * | 360M 30.05B | Net cash position 2025 * | 404M 33.68B | EV / Sales 2025 * | 5.61 x |
P/E ratio 2024 * |
132
x | P/E ratio 2025 * |
85
x | Employees | 797 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.93% |
Latest transcript on Axonics, Inc.
1 day | +0.23% | ||
1 week | -0.39% | ||
Current month | -3.31% | ||
1 month | -3.21% | ||
3 months | -1.94% | ||
6 months | +35.05% | ||
Current year | +7.17% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 51 | 01/13/01 | |
Raymond Cohen
FOU | Founder | 65 | 01/13/01 |
Kari Keese
DFI | Director of Finance/CFO | 39 | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Carrel
CHM | Chairman | 53 | 27/19/27 |
Nancy Snyderman
BRD | Director/Board Member | 72 | 08/19/08 |
Raymond Cohen
FOU | Founder | 65 | 01/13/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.98% | 11 M€ | -6.03% | - | |
0.09% | 509 M€ | -.--% | ||
0.05% | 773 M€ | -.--% | - | |
0.04% | 237 M€ | +2.89% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 66.69 | +0.23% | 318,433 |
25/24/25 | 66.54 | -0.15% | 484,280 |
24/24/24 | 66.64 | +0.26% | 396,114 |
23/24/23 | 66.47 | -0.55% | 1,069,674 |
22/24/22 | 66.84 | -0.16% | 670,197 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.17% | 3.4B | |
+12.07% | 128B | |
-9.04% | 10.65B | |
+0.91% | 8.82B | |
+16.72% | 7.19B | |
+25.15% | 4.99B | |
-1.36% | 3.03B | |
-8.73% | 2.14B | |
-10.15% | 2B | |
-22.81% | 1.79B |
- Stock Market
- Equities
- AXNX Stock